双重差异:维生素D缺乏和黑人男性致命的前列腺癌
Adriana Duraki1, Kirsten D Krieger1, Larisa Nonn2
1Department of Pathology, University of Illinois Chicago, Chicago, IL, USA.
The Journal of steroid biochemistry and molecular biology
|January 19, 2025
概括
黑人男性面临更高的前列腺癌死亡率,由于侵略性形式和维生素D缺乏. 解决维生素D水平的问题可能为这种差异提供新的预防和治疗策略.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 营养科学 营养科学
背景情况:
- 前列腺癌不成比例地影响黑人男性,发病率更高,侵袭性疾病,与欧洲男性相比,死亡率翻了一番.
- 这种持续存在的前列腺癌结果的种族差异已被广泛研究,但多因素的贡献者仍然没有确定性.
- 黑人男性的维生素D缺乏率更高,这种因素越来越与侵袭性和致命的前列腺癌有关.
研究的目的:
- 调查维生素D缺乏与前列腺癌之间的联系,特别是在黑人男性中.
- 探索维生素D在前列腺癌结果中观察到的种族差异中的潜在作用.
- 根据维生素D对前列腺癌生物学的影响,确定预防和治疗干预的潜在途径.
主要方法:
- 审查流行病学数据和关于前列腺癌种族差异的科学文献.
- 对与前列腺癌发病率,攻击性和死亡率相关联的维生素D水平研究的分析.
- 检查将维生素D缺乏与前列腺癌进展联系起来的生物机制.
主要成果:
- 强有力的证据表明,维生素D缺乏与致命形式的前列腺癌之间存在明显的关联.
- 黑人男性面临着双重差异:维生素D缺乏的风险更高,以及具有攻击性,致命的前列腺癌的风险更高.
- 观察到的维生素D和前列腺癌的差异扩展到全球的黑人人口,尽管研究集中在非洲裔美国男性身上.
结论:
- 维生素D缺乏是致命前列腺癌的重要因素,特别影响黑人男性.
- 了解维生素D与前列腺癌生物学之间的相互作用,可能会为预防和治疗提供新的策略.
- 解决维生素D缺乏症可能是缓解前列腺癌发病率的种族差异的关键组成部分.
相关概念视频
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
Lethal Alleles
15.4K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.4K
Disorders of the Male Reproductive System
354
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
354
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


